#011 — Endwell, New York

#011 is a clinical research site located in Endwell, New York, United States.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

#011 has participated in 1 clinical trials.

Therapeutic areas: Influenza.

Sponsors: MDVI, LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Endwell

Browse all research sites in New York · View every site in Endwell

• Regional Clinical Research
• Meridian Clinical Research
• GSK Investigational Site
• Research Site
• Pfizer Investigational Site
• Meridian Clinical Research (Endwell-New York) - Platinum - PPDS
• Endwell Family Physicians
• Novo Nordisk Investigational Site
• Novartis Investigative Site
• Local Institution
• Endwell Family Physician
• Research Site 10001-128

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for #011?

#011 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has #011 conducted?

#011 has 1 clinical trials on record. Their work covers Influenza.

Is #011 accredited by Crixeo Clinical Trials?

#011 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about #011?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.